- Home
- CMPX vs ZVRA Comparison
CMPX vs ZVRA Comparison
Compare CMPX & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- ZVRA
- Stock Information
- Founded
- CMPX 2014
- ZVRA 2006
- Country
- CMPX United States
- ZVRA United States
- Employees
- CMPX N/A
- ZVRA N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- CMPX Health Care
- ZVRA Health Care
- Exchange
- CMPX Nasdaq
- ZVRA Nasdaq
- Market Cap
- CMPX 408.6M
- ZVRA 433.5M
- IPO Year
- CMPX N/A
- ZVRA 2015
- Fundamental
- Price
- CMPX $1.95
- ZVRA $7.49
- Analyst Decision
- CMPX Strong Buy
- ZVRA Strong Buy
- Analyst Count
- CMPX 7
- ZVRA 8
- Target Price
- CMPX $12.43
- ZVRA $22.29
- AVG Volume (30 Days)
- CMPX 850.8K
- ZVRA 507.7K
- Earning Date
- CMPX 05-12-2025
- ZVRA 03-11-2025
- Dividend Yield
- CMPX N/A
- ZVRA N/A
- EPS Growth
- CMPX N/A
- ZVRA N/A
- EPS
- CMPX N/A
- ZVRA N/A
- Revenue
- CMPX $850,000.00
- ZVRA $23,612,000.00
- Revenue This Year
- CMPX $47.65
- ZVRA $281.10
- Revenue Next Year
- CMPX $3,909.48
- ZVRA $97.98
- P/E Ratio
- CMPX N/A
- ZVRA N/A
- Revenue Growth
- CMPX N/A
- ZVRA N/A
- 52 Week Low
- CMPX $0.77
- ZVRA $4.20
- 52 Week High
- CMPX $4.08
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- CMPX 31.88
- ZVRA 40.31
- Support Level
- CMPX $2.18
- ZVRA $7.78
- Resistance Level
- CMPX $2.17
- ZVRA $8.33
- Average True Range (ATR)
- CMPX 0.16
- ZVRA 0.40
- MACD
- CMPX -0.03
- ZVRA -0.04
- Stochastic Oscillator
- CMPX 14.60
- ZVRA 14.53
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.